The Scientific Advisors team at Rewind Therapeutics collaborates closely with key research and development personnel to guide the therapeutic innovation process for neurological diseases. They leverage their extensive expertise to provide strategic direction, assess scientific validity, and ensure that therapeutic approaches align with the latest advancements in the field. This team plays a crucial role in bridging the gap between scientific discovery and clinical application, facilitating the progression of novel treatments from laboratory to patient care.
Catherine Lubetzki
Scientific Advisor
Daguang Wang
Scientific Advisor
Giancarlo Comi
Scientific Advisor
Guillaume Duvey
VP Drug Discovery
Irene Knuesel
Chief Scientific Officer
Ricardo Hermosilla
Head of Translational Medicine
Robin Franklin
Scientific Advisor
Rui Costa Pinto
Principal Scientist, Medicinal...
Stephen Burbidge
Head of Research & Discovery
View all